Related Experiment Videos
Apoptosis induction resulting from proteasome inhibition
K Shinohara1, M Tomioka, H Nakano
1Department of Radiation Research, Tokyo Metropolitan Institute of Medical Science, Japan.
The Biochemical Journal
|July 15, 1996
Summary
Benzyloxycarbonyl (Z)-Leu-Leu-leucinal (ZLLLal), a proteasome inhibitor, induces apoptosis in cancer cells. This proteasome inhibition leads to p53 accumulation, suggesting a role for proteasomes in protecting cells from apoptosis.
Area of Science:
- Cell Biology
- Biochemistry
Background:
- Proteases play a crucial role in regulating cellular processes, including apoptosis.
- The involvement of specific protease families, like proteasomes and calpains, in apoptosis is an area of active research.
Purpose of the Study:
- To investigate the effect of benzyloxycarbonyl (Z)-Leu-Leu-leucinal (ZLLLal), a proteasome inhibitor, on apoptosis induction in cancer cell lines.
- To explore the role of proteasome inhibition in p53 accumulation and its relation to apoptosis.
Main Methods:
- Treatment of MOLT-4 and L5178Y cells with ZLLLal and other protease inhibitors.
- Assessment of apoptosis induction.
- Analysis of p53 protein levels using Western blotting or similar techniques.
Main Results:
- ZLLLal, a cell-permeant proteasome inhibitor, induced significant apoptosis in MOLT-4 and L5178Y cells.
- Calpain inhibitor I also induced apoptosis, but Z-Leu-leucinal, a specific calpain inhibitor, did not.
- Incubation with ZLLLal led to the accumulation of p53 protein in MOLT-4 cells.
Conclusions:
- Proteasome inhibition by ZLLLal triggers p53-dependent apoptosis.
- These findings suggest that proteasomes may function to protect cells from undergoing apoptosis.